Your browser doesn't support javascript.
loading
Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake.
Nilsson, Martin P; Nilsson, Erik D; Silfverberg, Barbro; Borg, Åke; Loman, Niklas.
Affiliation
  • Nilsson MP; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. martin.nilsson@med.lu.se.
  • Nilsson ED; Department of Hematology, Oncology and Radiation Physics, Skane University Hospital, Lund, Sweden. martin.nilsson@med.lu.se.
  • Silfverberg B; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
  • Borg Å; Department of Clinical Genetics, Laboratory Medicine Region Skåne, Lund, Sweden.
  • Loman N; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Genet Med ; 21(1): 89-96, 2019 01.
Article in En | MEDLINE | ID: mdl-29875420

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / BRCA1 Protein / BRCA2 Protein Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Genet Med Journal subject: GENETICA MEDICA Year: 2019 Type: Article Affiliation country: Sweden

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / BRCA1 Protein / BRCA2 Protein Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Genet Med Journal subject: GENETICA MEDICA Year: 2019 Type: Article Affiliation country: Sweden